{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:00:04Z","timestamp":1784098804382,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Mermaid Project"},{"DOI":"10.13039\/501100001729","name":"Swedish Foundation for Strategic Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.vaccine.2018.09.011","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T09:45:10Z","timestamp":1537523110000},"page":"6373-6378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions"],"prefix":"10.1016","volume":"36","author":[{"given":"Christian","family":"Dehlendorff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r","family":"Spar\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte","family":"Baldur-Felskov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Herweijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisen","family":"Arnheim-Dahlstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Ploner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Uhnoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne K.","family":"Kjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.09.011_b0005","unstructured":"Human papillomavirus vaccines: WHO position paper, October 2014. Wkly Epidemiol Rec 2014;89(43):465-91."},{"issue":"37","key":"10.1016\/j.vaccine.2018.09.011_b0010","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1016\/j.vaccine.2013.06.060","article-title":"Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review","volume":"31","author":"Fesenfeld","year":"2013","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2018.09.011_b0015","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1016\/S2214-109X(14)70237-2","article-title":"Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study","volume":"2","author":"Jit","year":"2014","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.vaccine.2018.09.011_b0020","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1471-2334-11-174","article-title":"Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden","volume":"11","author":"Kim","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2018.09.011_b0025","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S1470-2045(14)70481-4","article-title":"Present status of human papillomavirus vaccine development and implementation","volume":"16","author":"Herrero","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2018.09.011_b0030","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djt032","article-title":"Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study","author":"Leval","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2018.09.011_b0035","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djt460","article-title":"Early impact of human papillomavirus vaccination on cervical neoplasia-nationwide follow-up of young Danish women","author":"Baldur-Felskov","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2018.09.011_b0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1741-7015-11-227","article-title":"Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study","volume":"11","author":"Gertig","year":"2013","journal-title":"BMC Medicine"},{"issue":"5","key":"10.1016\/j.vaccine.2018.09.011_b0045","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1200\/JCO.2013.52.4645","article-title":"Effectiveness of the quadrivalent human papillomavirus vaccine against cervical dysplasia in Manitoba","volume":"32","author":"Mahmud","year":"2014","journal-title":"Canada J Clin Oncol"},{"issue":"1","key":"10.1016\/j.vaccine.2018.09.011_b0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.vaccine.2012.10.092","article-title":"Impact of human papillomavirus (HPV) vaccination on HPV 16\/18-related prevalence in precancerous cervical lesions","volume":"31","author":"Powell","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.011_b0055","doi-asserted-by":"crossref","first-page":"g1458","DOI":"10.1136\/bmj.g1458","article-title":"Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia","volume":"348","author":"Crowe","year":"2014","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.vaccine.2018.09.011_b0060","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/jama.2014.95","article-title":"Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma","volume":"311","author":"Herweijer","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.vaccine.2018.09.011_b0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish national patient register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7","key":"10.1016\/j.vaccine.2018.09.011_b0070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish national prescription registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.vaccine.2018.09.011_b0075","unstructured":"http:\/\/www.ssi.dk\/Aktuelt\/Nyhedsbreve\/EPI-NYT\/2013\/Uge%2020%20-%202013.aspx?p=1%20SSIE-NH-v-t. [in Danish] [Accessed 20161208]."},{"key":"10.1016\/j.vaccine.2018.09.011_b0080","unstructured":"Folkh\u00e4lsomyndigheten. Vaccinationsregister https:\/\/www.folkhalsomyndigheten.se\/folkhalsorapportering-statistik\/statistikdatabaser-och-visualisering\/vaccinationsstatistik\/statistik-for-hpv-vaccinationer\/ [in Swedish] [Accessed 20161208]."},{"key":"10.1016\/j.vaccine.2018.09.011_b0085","unstructured":"Socialstyrelsen. L\u00e4kemedelsregistret http:\/\/www.socialstyrelsen.se\/register\/halsodataregister\/lakemedelsregistret [Accessed 20161208]."},{"key":"10.1016\/j.vaccine.2018.09.011_b0090","unstructured":"TDPDB. 2011. Available from: http:\/\/www.patobank.dk\/ [in Danish] [Accessed 20161208]"},{"key":"10.1016\/j.vaccine.2018.09.011_b0095","unstructured":"Registry SNCS. http:\/\/nkcx.se\/index_e.htm [Accessed 20161208]."},{"key":"10.1016\/j.vaccine.2018.09.011_b0100","unstructured":"Socialstyrelsen. The Swedish Cancer Registry 2014. Available from: http:\/\/www.socialstyrelsen.se\/register\/halsodataregister\/cancerregistret\/inenglish [Accessed 20161208]"},{"key":"10.1016\/j.vaccine.2018.09.011_b0105","unstructured":"Development Core Team R. A language and environment for statistical computing. R foundation for statistical computing [Internet]. 2012. Available from: URL: http:\/\/www.R-project.org [Available from 20161208]."},{"key":"10.1016\/j.vaccine.2018.09.011_b0110","unstructured":"Carstensen BPM, Laara E, Hills M. Epi: A package for statistical analysis in epidemiology. R package version 1.1.24. webpage 2011 Available from: URL: http:\/\/CRAN.R-project.org\/package=Epi. 2011. Accessed 20161208"},{"issue":"6","key":"10.1016\/j.vaccine.2018.09.011_b0115","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/infdis\/jis405","article-title":"Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability","volume":"206","author":"Leval","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.09.011_b0120","doi-asserted-by":"crossref","first-page":"f2032","DOI":"10.1136\/bmj.f2032","article-title":"Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data","volume":"346","author":"Ali","year":"2013","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.vaccine.2018.09.011_b0125","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/OLQ.0b013e31827bd66b","article-title":"Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program","volume":"40","author":"Baandrup","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2018.09.011_b0130","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2340\/00015555-1721","article-title":"A reduced national incidence of anogenital warts in young Danish men and women after introduction of a national quadrivalent human papillomavirus vaccination programme for young women\u2013an ecological study","volume":"94","author":"Sando","year":"2014","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.vaccine.2018.09.011_b0135","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis","volume":"15","author":"Drolet","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2018.09.011_b0140","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/cid\/cit436","article-title":"Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark","volume":"57","author":"Blomberg","year":"2013","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"issue":"5","key":"10.1016\/j.vaccine.2018.09.011_b0145","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cid\/civ364","article-title":"Dose-related differences in effectiveness of human papillomavirus vaccination against genital warts: a nationwide study of 550,000 young girls","volume":"61","author":"Blomberg","year":"2015","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"issue":"17","key":"10.1016\/j.vaccine.2018.09.011_b0150","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.2013.1625","article-title":"Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial","volume":"309","author":"Dobson","year":"2013","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.vaccine.2018.09.011_b0155","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.vaccine.2015.01.084","article-title":"Reduction in HPV 16\/18-associated high grade cervical lesions following HPV vaccine introduction in the United States \u2013 2008\u20132012","volume":"33","author":"Hariri","year":"2015","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2018.09.011_b0160","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1002\/ijc.30035","article-title":"Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: a population-based study","volume":"138","author":"Herweijer","year":"2016","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.vaccine.2018.09.011_b0165","doi-asserted-by":"crossref","first-page":"e0134185","DOI":"10.1371\/journal.pone.0134185","article-title":"The participation of HPV-vaccinated women in a national cervical screening program: population-based cohort study","volume":"10","author":"Herweijer","year":"2015","journal-title":"PLoS One"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T19:44:39Z","timestamp":1538682279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18312581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":33,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0264410X18312581"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}